Today’s Yangtze funding roundup: therapy, biotech, robotics, spectroscopy…
Yangtze River Delta companies in proton therapy, spectroscopy, electronic gases, biotech and robotics raised fresh capital.
Month: September 2026
Read More
DeepSeek opens Ascend software stack, bolsters China’s AI chips
The company credited Huawei’s team with providing what it described as strong and extensive support during development.
Alibaba shifts gears, offloads ecosystem assets as AI takes the wheel
AI changes the equation. The scarce assets are increasingly computing power, chips, data-center capacity and cloud infrastructure.
Anhui bets big on top-tier humanoid robotic sector with 2030 output goal
The policy encourages global acquisitions and supply-chain integration, while supporting automakers’ expansion into robotics.
DEEP Robotics revenue nearly doubles as profit swings back to loss
DEEP Robotics’ industrial focus broadens its applications but requires more upfront investment and customization.
CXMT puts shy of $2.7B of excess IPO proceeds into DRAM R&D, testing
The company had 36.8 billion yuan in excess proceeds, making the latest 18 billion yuan allocation almost half of that pool.
PrimeBot opens first global store as personal robots enter retail
PrimeBot’s retail expansion also offers an early test of how China’s emerging personal-robot market could develop.
Hengrui licenses obesity drug to Novo Nordisk in deal worth up to $2.6B
This transaction comes as the Danish drugmaker expands its pipeline of next-generation weight-loss treatments.
Today’s Yangtze funding roundup: medtech, wafer, fusion, eye drug, AIGC…
The funding will support clinical development, reactor design, medical commercialization and AI platform expansion.
MiniMax launches M3.1-Flash-Preview with 1 million-token context
MiniMax positions it as an end-to-end coding model that can take a software task from diagnosis through delivery.